Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech's $6 Billion Best-Seller

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Amgen, Allergan Make History With First Cancer Biosimilar OKWill Take on Genentech's $6 Billion Best-Seller" ALT"Amgen, Allergan Make History With First Cancer Biosimilar OKWill Take on Genentech's $6…

Continue ReadingAmgen, Allergan Make History With First Cancer Biosimilar OK&mdash;Will Take on Genentech's $6 Billion Best-Seller

Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingCatabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society

Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC" ALT"Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC"September 15, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR... Source: BioSpace

Continue ReadingMassachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC

Show Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Show Me The Money: Bay Areas Top 5 Venture Capital-Backed Biotechs" ALT"Show Me The Money: Bay Areas Top 5 Venture Capital-Backed Biotechs"September 15, 2017By Mark Terry, BioSpace.com Breaking…

Continue ReadingShow Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs

Novartis AG Unloads Former New York Space for $18 Million, Resold for $30 Million

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x600-novartis.jpg" NAME"Novartis Unloads Former New York Space for $18 Million, Resold for $30 Million" ALT"Novartis Unloads Former New York Space for $18 Million, Resold for $30 Million"September 15, 2017By…

Continue ReadingNovartis AG Unloads Former New York Space for $18 Million, Resold for $30 Million

Bavarian Nordic Plummets 49% After Cancer Vaccine Flunks Late-Stage Test

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Bavarian Nordic Plummets 49% After Cancer Vaccine Flunks Late-Stage Test" ALT"Bavarian Nordic Plummets 49% After Cancer Vaccine Flunks Late-Stage Test"September 15, 2017By Alex Keown, BioSpace.com Breaking... Source: BioSpace

Continue ReadingBavarian Nordic Plummets 49% After Cancer Vaccine Flunks Late-Stage Test